PIK-PD-1 cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PIK-PD-1 cells, covering 2016-01-01 to 2016-01-01. Get the full timeline:
Most recent: Clinical Trial Update: Immunotherapy Using Pluripotent Killer-Programmed Cell Death 1 (PIK-PD-1) Cells for the Treatment of Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]